Chronic exposure to glucocorticoids has been shown to reduce the levels of brain‐derived neurotrophic factor (BDNF) and its receptor, tyrosine kinase receptor B (TrkB), in brain structures involved in depression and the regulation of cognitive and emotional processes (Adcock and Glucocorticoids 2017). Here, NTRK2 is linked to depressive symptom measurement.